Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/16545
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNattawat Onlamoonen_US
dc.contributor.authorSutchana Tabprasiten_US
dc.contributor.authorSurapol Suwanagoolen_US
dc.contributor.authorSuda Louisirirotchanakulen_US
dc.contributor.authorAftab A. Ansarien_US
dc.contributor.authorKovit Pattanapanyasaten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherEmory Universityen_US
dc.date.accessioned2018-06-21T08:14:57Z-
dc.date.available2018-06-21T08:14:57Z-
dc.date.issued2005-10-25en_US
dc.identifier.citationVirology. Vol.341, No.2 (2005), 238-247en_US
dc.identifier.issn10960341en_US
dc.identifier.issn00426822en_US
dc.identifier.other2-s2.0-26244451383en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=26244451383&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/16545-
dc.description.abstractThe monitoring of the efficacy of anti-retroviral therapy (ART) is becoming an important issue in the developing world. The current use of CD4 counts, plasma viral loads, and monitoring of drug-resistant viruses are at present either uninformative or costly. Thus, more new cost-effective and practical techniques need to be established and implemented. Towards this goal, our lab has carried out studies on the potential use of CD38 frequency and density expression by flow analysis as a means to assess the efficacy of ART. Results of our studies using whole blood sample from normal healthy donors indicate that CD38 is expressed by a high frequency of not only CD4+ and CD8+ T cells but also most hematopoietic cell lineages analyzed. Detailed studies of CD38 expression along with other cell surface markers using whole blood sample from HIV-1-infected patients showed that the most discriminating change was the increased frequency and density of CD38 expression by CD3+CD8+ T cells. Of importance was our preliminary finding that a reversal of the increased frequency and density of CD38 expression by CD8+ T cells only appeared in the whole blood sample from patients who were responders to ART but not those who were drug failures. These initial data provide a platform and incentive for larger cohort studies including prospective pre- and post-ART for the institution of such monitoring techniques in resource limited settings. © 2005 Elsevier Inc. All rights reserved.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=26244451383&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleStudies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailanden_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.1016/j.virol.2005.07.018en_US
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.